BlackRock, Inc. 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
9,042,979 7.500% |
2,546,386 (+39.20%) |
Filing |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
6,496,593 8.800% |
1,210,419 (+22.90%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
5,286,174 8.000% |
1,988,694 (+60.31%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
3,297,480 7.000% |
1,268,223 (+62.50%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
2,029,257 5.400% |
2,029,257 (New Position) |
Filing |